U.S. Stock News

Why Satellogic Stock Is Back on Investors’ Radar Satellogic (SATL) has drawn fresh interest after reporting second quarter and first half 2026 results on 5 August, with higher revenue figures alongside wider losses catching the attention of investors. The company posted second quarter revenue of US$15.92 million, compared with US$4.44 million a year earlier. Net loss widened to US$20.05 million from US$6.65 million. Basic loss per share from continuing operations was US$0.13, compared with...

AIG stock slipped about 1.5% today to roughly US$78. Yet the latest quarter showed another solid underwriting performance that keeps the long term story very much alive. Adjusted after tax income came in at US$1.1b and core operating return on equity was about 11% for the quarter, supported by a General Insurance combined ratio below 90%. While the immediate price reaction looks muted, the more important developments are in underwriting discipline, capital returns and the multiyear push to...

Global Partners came into this print with a solid recent run and a stock at about $50 that already reflected some optimism. The 3.4% pop after earnings indicates that investors liked what they saw. The headline is simple: profitability in this fuel and convenience network looks much stronger, with Q2 net income of $71.0 million and adjusted earnings before interest, tax, depreciation and amortization of $148.2 million. For income-focused holders, the raised quarterly cash distribution to...

Warner Bros. Discovery reported past second-quarter 2026 results showing revenue slipping to US$8,717 million from US$9,812 million a year earlier, while quarterly net income fell to US$149 million and the first half swung to a US$2.77 billion net loss from a US$1.13 billion profit. Behind these weaker headline numbers, the company’s streaming arm surpassed US$3 billion in quarterly revenue, helped by the Max–Disney+–Hulu bundle that reduced churn, even as management continued to back the...

Calumet stock dropped 5.7% to close at US$39.48 after its latest earnings, even though the quarter featured one clear headline. The company produced US$175m of adjusted earnings before interest, tax, depreciation and amortization, and generated more than US$90m of cash from operations, while continuing to pay down debt. In the short term, traders are reacting to a red price screen. Over a multi year horizon, the real story is the balance sheet repair. Management is retiring higher cost...

Array Digital Infrastructure came into this earnings release with a bruised share price and a value label. The stock has fallen about 33% over the past three months, yet still trades on a trailing P/E of 4.6x compared with much richer wireless tower peers. Then Q2 landed with a jolt. Basic earnings per share jumped to US$3.86 and net income from ongoing operations reached US$333.77 million. The market barely flinched, with the stock slipping 1.1% to US$35.24 after the report. That muted move...

Star Bulk Carriers has delivered a 151.7% total return over the past five years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples still point to the stock trading at a discount of around 40.1% to fair value. That mix of strong long term performance and ongoing valuation gap is drawing fresh attention after the latest earnings update and fleet expansion plans. Over five years the stock is up 151.7%, which means long term holders have already seen...

Fluor stock just put in a 16.9% one day jump, and that kind of move demands a sanity check. The headline is not a one off accounting quirk. Investors are reacting to a construction and engineering giant that delivered Q2 revenue of US$4.3b and adjusted earnings per share of US$0.91, while locking in US$6.1b of new awards and pushing backlog toward US$27b. The real story is whether this surge reflects a clean reset of sentiment on Fluor’s order book and earnings power, or if buyers are...

Why Gulfport Energy’s latest quarter is drawing attention Gulfport Energy (GPOR) has moved into focus after second quarter results showed lower quarterly revenue, net income, and production, alongside fresh full year production guidance and the upcoming resignation of its Chief Financial Officer. For you as an investor, this cluster of updates raises several questions. The mix of softer quarterly metrics, leadership change at the finance helm, and new production targets can influence how you...

Trip.com Group stock has delivered an 86.1% gain over the past 5 years, yet the broader valuation checks still suggest the shares lean cheap. Recent share price weakness in 2026 leaves investors weighing that longer term return against a high value score and mixed shorter term performance. Over 5 years, Trip.com Group is up 86.1%, which points to meaningful value creation for longer term holders despite recent setbacks. The 2025 Sustainability Report and the new US$100 million Tourism...

Douglas Elliman slipped 0.6% to US$1.78 after its second quarter report, a muted move for a stock tied to luxury housing sentiment. The headline is not the price; it is the sharp improvement in the income statement. Revenue was US$283.4m and the quarterly loss narrowed to US$2.7m. For a brokerage that only recently turned profitable on a trailing basis, that combination turns today’s dip into a sentiment check rather than a clear verdict. The rest of the report shows how fragile or durable...

In the second quarter of 2026, Upbound Group, Inc. reported sales of US$903.7 million, revenue of US$1.16 billion, and net income of US$21.58 million, with basic earnings per share from continuing operations of US$0.37, all modestly higher than a year earlier. The company also narrowed its full-year 2026 consolidated revenue outlook to US$4.70–US$4.85 billion and issued third-quarter revenue guidance of US$1.05–US$1.15 billion, giving investors a clearer view of expected scale and earnings...

A surprise loss of 23,000 US jobs in July and softer wage growth has put resilience back in the spotlight. Healthcare giants in areas such as pharmaceuticals and medical equipment are often watched closely when the broader economy looks less certain, because demand for many treatments can remain steady. This article reveals 3 large healthcare stocks from our screener that appear well placed against this backdrop. The three stocks highlighted below are just a sample from this theme, with the...

Biglari Holdings stock barely flinched after earnings, easing just 0.3%, yet the headline result was anything but quiet. A swing to basic earnings per share of US$158.17 for the quarter, alongside net income of US$39.93 million, marks a sharp break from the recent run of losses. The market still treats Biglari as an unprofitable story with stretched valuation, which sets up a sentiment clash between the trailing weakness and a powerful single quarter of profitability. Is Biglari Holdings now...

In late July 2026, Align Technology reported second-quarter 2026 results showing sales rising to US$1,056.19 million year-on-year, issued softer sequential revenue guidance for the third quarter, and outlined the impact of one-time restructuring, depreciation, and legal charges on its GAAP operating margin outlook. At the same time, after discussions with Elliott Investment Management, Align committed to appoint three new independent directors, launched a comprehensive strategic and...

ANI Pharmaceuticals just took a 5.3% hit in a single session, yet the earnings story looks more like growing pains than a broken thesis. You have a stock that came into the print soft over the past month, then sold off again right after reporting adjusted earnings per share of US$2.21 on revenue of US$266.0m. The real swing factor is profit quality. Investors appear to be wrestling with how much of the recent profitability and trailing US$259.6m of adjusted EBITDA reflects repeatable rare...

Embecta entered this quarter wearing the label of a deeply discounted diabetes device stock, with a single digit P/E and significant balance sheet questions. The market lifted the share price 26% to US$4.42 in the first session after earnings. The move reflects one headline takeaway: the business reported a sharp rebound in both revenue and profit, with Q3 sales of US$271.7m and net income of US$21.1m after a loss in Q2. For a company under pressure over debt and cash generation, that...

In late July 2026, Laureate Education, Inc. reported second-quarter sales of US$615.86 million and net income of US$137.1 million, alongside higher first-half earnings and an updated full-year 2026 revenue outlook of US$1.92 billion to US$1.93 billion, implying 13% as-reported growth. At the same time, Laureate expanded its share repurchase effort, having already bought back 13,863,000 shares for US$399.61 million and adding a further US$250 million authorization, highlighting management’s...

Under Armour stock fell about 4.5% to US$6.11 in the first trading session after its Q1 2027 report, adding fresh pressure to an already weak one month stretch. At first glance the reaction looks harsh for a company that just posted a small profit and stronger than expected adjusted operating income. The real headline is not the quarter. It is the decision to cut full year revenue guidance to a mid single digit decline while still holding the US$140 million to US$160 million adjusted...

Praxis Precision Medicines (NasdaqGS: PRAX) reported new clinical and regulatory milestones across its central nervous system pipeline, including progress on several drug candidates. The company received FDA Breakthrough Therapy designation for Elsunersen, its investigational treatment for neurological disorders. Praxis expanded its CNS program through collaborations and licensing agreements with partners including RogCon Inc. and Ionis Pharmaceuticals. This kind of pipeline and partnership...

BridgeBio Pharma (BBIO) has drawn fresh attention after recent share price moves, with the stock closing at $84.48 on 6 August 2026. Investors are weighing this level against the company’s longer term return profile. See our latest analysis for BridgeBio Pharma. The latest move in BridgeBio Pharma’s share price builds on a 30.61% 90 day share price return and an 81.37% 1 year total shareholder return. However, the 30 day share price return of 1.64% shows some cooling in the very short...

UWM Holdings Corporation recently reported a Q2 2026 net loss of US$80.59 million, reversing from net income of US$22.91 million a year earlier, and filed an omnibus shelf registration covering multiple securities classes, while also suspending its dividend and raising new capital amid a pressured mortgage market. This combination of weaker profitability, dividend suspension, and added capital-raising flexibility signals a renewed focus on balance sheet strength and financial resilience for...

After a strong three-year run that has seen Gates Industrial stock return about 139%, the current share price now sits against an intrinsic value estimate that still points to upside, while the broader valuation checks paint more of a mixed picture. The roughly 139% return over three years puts Gates Industrial in clear outperformer territory, so the key issue now is whether the current price still leaves room for further value. Recent earnings strength and upgraded expectations can support...

Compass, Inc. recently reported past second-quarter 2026 results showing sales of US$4.31 billion and net income of US$92 million, alongside significantly higher revenue and earnings for the first half of the year compared with the prior period. The swing from a net loss to a net profit over the first six months of 2026, together with higher basic and diluted earnings per share, highlights a meaningful improvement in Compass’s profitability profile. We’ll now examine how Compass’s sharp...